Bacillus Calmette-Guérin treatment of 39 patients with superficial transitional cell carcinoma of the bladder.

al Khalifa, M A; Elfving, P; Månsson, W; Colleen, S

al Khalifa, M A; Elfving, P; Månsson, W; Colleen, S.

Affiliation

al Khalifa MA; Department of Urology, University Hospital, Lund, Sweden.

Scand J Urol Nephrol ; 25(2): 135-9, 1991.

Article in En | MEDLINE | ID: mdl-1871559

Subject(s)

BCG Vaccine/therapeutic use; Carcinoma, Transitional Cell/therapy; Urinary Bladder Neoplasms/therapy; Administration, Intravesical; Aged; BCG Vaccine/adverse effects; Carcinoma in Situ/pathology; Carcinoma in Situ/therapy; Carcinoma, Transitional Cell/pathology; Drug Administration Schedule; Female; Humans; Male; Neoplasm Recurrence, Local/therapy; Urinary Bladder/pathology; Urinary Bladder Neoplasms/pathology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / BCG Vaccine / Carcinoma, Transitional Cell Limits: Aged / Female / Humans / Male Language: En Journal: Scand J Urol Nephrol Year: 1991 Type: Article Affiliation country: Sweden

Search on Google

XML

PubMed Links